These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 19841605

  • 1. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia.
    Bialek SR, Helgenberger L, Fischer GE, Bower WA, Konelios M, Chaine JP, Armstrong G, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2010 Jan; 29(1):18-22. PubMed ID: 19841605
    [Abstract] [Full Text] [Related]

  • 2. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J, Li RC, Yang JY, Li YP, Chen XR, Xu ZY, Liu CB, Cao HL, Zhao K, Ni DM.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH, Chen DS.
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [Abstract] [Full Text] [Related]

  • 4. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH, Chen JD, Cheng SH, Sung KY, Jeng JJ, Chu FY.
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [Abstract] [Full Text] [Related]

  • 5. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ, Lawrence M, Scott C, Le Q, Lambert S, Farley TA.
    Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
    [Abstract] [Full Text] [Related]

  • 6. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F, Perez L, de Neira M, Hall AJ.
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF.
    Vaccine; 2004 Jul 29; 22(21-22):2791-9. PubMed ID: 15246613
    [Abstract] [Full Text] [Related]

  • 8. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ, Hahné S, Cremer J, Wong A, Boland G, van Loon AM.
    J Viral Hepat; 2010 Dec 29; 17(12):872-8. PubMed ID: 20051008
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
    Doherty R, Garland S, Wright M, Bulotsky M, Liss C, Lakkis H, Nikas A, Straus W.
    Pediatr Infect Dis J; 2009 Sep 29; 28(9):777-81. PubMed ID: 19636283
    [Abstract] [Full Text] [Related]

  • 10. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
    Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY.
    J Med Virol; 2007 Feb 29; 79(2):138-43. PubMed ID: 17177303
    [Abstract] [Full Text] [Related]

  • 11. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
    Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM.
    Saudi Med J; 2003 Sep 29; 24(9):991-5. PubMed ID: 12973485
    [Abstract] [Full Text] [Related]

  • 12. Seroprevalence of hepatitis B infection in the Turkish population in Northern Cyprus.
    Kurugöl Z, Koturoğlu G, Akşit S, Ozacar T, Northern Cyprus Study Team, Kayimbaşoğlu S, Ozbalikçi S, Erçal G, Güllüelli E, Bakkaloğlu F, Doğan E, Garabli H, Erçal H, Mert C.
    Turk J Pediatr; 2009 Sep 29; 51(2):120-6. PubMed ID: 19480322
    [Abstract] [Full Text] [Related]

  • 13. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
    Danielsson N, Fakakovikaetau T, Szegedi E.
    Vaccine; 2009 Jul 16; 27(33):4462-7. PubMed ID: 19508908
    [Abstract] [Full Text] [Related]

  • 14. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct 16; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization.
    Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, Paupunwatana S, Chaiear K, Khwanjaipanich S, Poovorawan Y.
    Trop Med Int Health; 2006 Oct 16; 11(10):1496-502. PubMed ID: 17002723
    [Abstract] [Full Text] [Related]

  • 16. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY, Ko WC, Tsai JJ, Lee HC, Liu CE, Wong WW, Su SC, Ho MW, Cheng SH, Yang CH, Lin YH, Miao WJ, Sheng WH, Hung CC.
    Am J Gastroenterol; 2009 Apr 16; 104(4):877-84. PubMed ID: 19259078
    [Abstract] [Full Text] [Related]

  • 17. The hepatitis B immunization campaign for children in the Federated States of Micronesia.
    Manea SJ, Iohp K.
    Public Health Rep; 1992 Apr 16; 107(5):556-61. PubMed ID: 1410237
    [Abstract] [Full Text] [Related]

  • 18. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
    Xia G, Jia Z, Yan T, Li R, Liu H, Xu Z, Cao H, Liu C.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun 16; 16(2):146-9. PubMed ID: 12196826
    [Abstract] [Full Text] [Related]

  • 19. An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net.
    Fischer G, Wang S, Ahring S, Fowler K, Hainline S, Chinglong M, Jacques-Carroll L, Bell B, Williams I.
    Pediatr Infect Dis J; 2009 Jul 16; 28(7):593-7. PubMed ID: 19455073
    [Abstract] [Full Text] [Related]

  • 20. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 16; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.